EMBL
Alex Bateman (IBTT)
Bacterial cell surface proteins, host-pathogen interactions, deep learning
Maria Bernabeu Aznar (IBTT)
Malaria pathogenesis, blood-brain barrier models, vascular inflammation
Sagar Bhogaraju (IBTT)
Ubiquitination pathways, bacterial effector proteins, Legionnaires’ disease
Peer Bork (METT)
Metagenomics, microbial communities, global microbiomes
Matthieu Boulard (IBTT)
Epigenetic gene silencing, adaptive immune response, epigenomic profiling
Matthew Bowler (IBTT)
Host reaction to infection, Toxoplasma gondii , inflammatory response
Guy Cochrane (IBTT)
Nucleotide sequence data, disease surveillance, vaccine development
Alvaro Hernan Crevenna Escobar (IBTT)
Light imaging, host-pathogen interactions, immune response
Gautam Dey (IBTT)
Nuclear organisation, malaria parasite, cell cycle network
Robert Finn (METT)
Metagenomic data, microbial diversity, genome reconstruction
Maria Marta Garcia Alai (METT)
Structural biology, protein-lipid interactions, endocytosis
Nick Goldman (IBTT)
Molecular evolution, machine learning, viral genome data
Jan Kosinski (IBTT)
Influenza virus, structural biology, pathogen interactions
Eva Kowalinski (IBTT)
RNA processing, Trypanosoma parasites, X-ray crystallography and cryo-electron microscopy
Andrew Leach (IBTT)
Drug discovery, antimicrobial agents, biological processes
John Lees (IBTT, METT)
Pathogen informatics, genomic epidemiology, bioinformatics tools
Julia Mahamid (IBTT)
Mycoplasma pneumoniae, RNA viruses, protein synthesis machinery
José Márquez (IBTT)
Macromolecular crystallography, therapeutic targets, small-molecule inhibitors
Maria-Jesus Martin (METT)
Bioinformatics tools, protein sequence, UniProt database
Simone Mattei (IBTT)
Protozoan parasites, cryo-electron tomography, mitochondrial ribosomes
Evangelia Petsalaki (IBTT)
Human cell signalling, pathogen interactions, network biology
Julio Saez Rodriguez (METT)
Cellular network deregulation, big data integration, disease therapeutics
Mikhail Savitski (METT)
Stability proteomics, Thermal Proteome Profiling, drug discovery
Nassos Typas (IBTT, METT)
Microbial systems biology, antibiotic resistance, bacterial networks
Jordi van Gestel (METT)
Microbial development, predation, mathematical modelling
Flora Vincent (METT)
Marine microbial interactions, symbiosis, carbon cycling
Matthias Wilmanns (IBTT)
Mycobacterial secretion mechanism, type VII secretion, structural biology
David Yuan (IBTT)
Genomic analysis, SARS-CoV-2, quantum computing algorithms
Judith Zaugg (IBTT)
Epigenetic variation, immunology, single-cell multiomics
Maria Zimmermann (METT)
Gut bacteria, computational modelling, multi-omics data
Michael Zimmermann (METT)
Gut microbiome, enzyme-encoding genes, drug metabolism
MIMS
Iker Aramburu
Illuminating the dark proteome in innate immunity
Ellen Bushell
Parasite-host interactions that govern malaria infection and disease
Lars-Anders Carlson
Structure and mechanism of viral replication complexes
Laura Carroll
Bioinformatic approaches to monitor and combat the spread of bacterial pathogens
Chinmay Dwibedi
Human gut microbes at high resolution, adaptive evolution and functional variation across bacterial strains.
André Mateus
Mapping protein function in human gut microbiome species using proteomics and systems biology
Ryo Morimoto
Immune system evolution; cytidine deaminases in adaptive immunity and genome editing
Björn Schröder
Interaction between diet, gut microbiota and mucosal barrier function
Barbara Sixt
Cell-autonomous immunity and bacterial evasion strategies
HZI
Yannic Bartsch
Fc biology, antibody Fc, Fc effector functions, Fc engineering, monoclonal antibodies, systems Serology
Melanie Brinkmann
Innate immunity, herpesviral immune modulation, receptor signalling and trafficking, Type I interferon response, bone morphogenetic proteins, cytokines
Mark Brönstrup
Antibacterial and antiviral drug discovery and optimization, antibacterial drug conjugates, PROTACs, mode of action studies through metabolomics, intracellular drug quantification, peptide arrays
Dunja Bruder
Influenza, Influenza-pneumococcal co-infection, murine infection models, mucosal immunity, ex vivo immune cell phenotyping (FACS, transcriptional profiling), alveolar type II epithelial cells as targets for and responders to infections, prophylactic and therapeutic interventions (e.g. induction of the antiviral state by targeted stimulation of the interferon system), vaccination (systemic/ mucosal; protein, RNA, defective interfering particles)
Luka Cicin-Sain
Pseudovirus neutralisation assay, mutational scanning, virus reverse genetics, SARS-CoV-2, herpesvirus, RSV, Influenza, VSV, vaccine vector development, in vivo animal models, functional T cell assays, live cell imaging, CMV latency, dynamic transcriptomics at single-cell level
Franziska Faber
Clostridioides difficile , RNA-based mechanisms of virulence regulation, heterogeneity of virulence processes, microbial interactions, gut organoids
Susanne Häußler
Clinical isolates, molecular diagnostics, AMR, genotype-phenotype correlation
Lina Herhaus (starting October 2024)
Host-pathogen interactions, autophagy, innate immunity
Jens Hör
Phages, bacterial immunity, RNA
Ulrich Kalinke
Monoclonal antibodies, human dendritic cells and infection, infection mouse models, neuroinfection
Michael Kolbe
Cellular microbiology, bacterial infection, molecular infection mechanisms, Gram-negative pathogens, host pathogen interactions, secretion systems
Martin Korte
Viral infection, neuroinflammation, neurodegeneration, memory, brain fog, long COVID
Yang Li
Genetic regulation, immune phenotypes, immune responses, infection and vaccination, multi-omics integration, single cell genomics, spatial genomics
Michael Meyer-Hermann
Systems immunology, mathematical models, infection dynamics, host-pathogen interaction, adaptive immunity, whole body research.
Josef Penninger
Complex organoids, host-pathogen interactions, human tissue engineering, ACE2-molecular decoys, microbial effectomes, lectin applications
Frank Pessler
Vaccination strategies, high-risk individuals, biomarker discovery, mass spectrometry, RNA sequencing, therapeutic targets
Thomas Pietschmann
Respiratory viruses, hepatitis viruses, RSV, determinants of severe infection, antivirals, vaccines
Emmanuel Saliba
Single-cell RNA-seq, spatial transcriptomics, RNA biology, intestinal infection, clinics
Hortense Slevogt
Bacterial interaction, immune responses, respiratory microbiome, epithelial models, air-liquid interface, precision cut lung slices
Till Strowig
Microbiome, colonisation resistance, MDR enterobacterales, microbiome-based therapeutics, Klebsiella, Segatella/Prevotella
Jörg Vogel
RNA biology of bacterial infections
Wellcome Sanger Institute
Stephen Bentley
Bacterial respiratory pathogens, vaccine evasion, vaccine design, antibiotic resistance, infection control
Josie Bryant
Respiratory microbiome, chronic lung conditions, metagenomics, single-cell transcriptomics, microbiome-host interactions
Ewan Harrison
Respiratory viruses, genomic surveillance, metagenomics, antimicrobial resistance, pandemic threats
Trevor Lawley
Host-microbiota interactions, gut bacteria, microbiome assembly, pathogen colonisation resistance, immune development
Nicholas Thomson
Bacterial genomics, evolution, phylogeography, antimicrobial resistance, diarrhoeal disease, STIs